These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4696810)

  • 21. DOPA DECARBOXYLASE ACTIVITY IN THE SKIN.
    MOELLER H
    Acta Derm Venereol; 1963; 43():485-90. PubMed ID: 14061560
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro inhibition of dopa decarboxylase by 6-alkyl derivatives of 3-(3,4-dihydroxyphenyl)alanine (dopa).
    Morgenstern AP; Nauta WT
    Arzneimittelforschung; 1972 Oct; 22(10):1766-8. PubMed ID: 4677070
    [No Abstract]   [Full Text] [Related]  

  • 23. Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.
    Tate SS; Sweet R; McDowell FH; Meister A
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2121-3. PubMed ID: 5289372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ON FORMATION OF NORADRENALINE IN THE SKIN: ACTIVITY OF DOPAMINE-BETA-OXIDASE.
    MOELLER H
    Acta Derm Venereol; 1963; 43():548-51. PubMed ID: 14088645
    [No Abstract]   [Full Text] [Related]  

  • 25. METABOLISM OF DOPA-14C IN THE NORMAL AND ALPHA-METHYLDOPATREATED MOUSE.
    WEISS B; ROSSI GV
    Biochem Pharmacol; 1963 Dec; 12():1399-405. PubMed ID: 14096427
    [No Abstract]   [Full Text] [Related]  

  • 26. Parkinson's disease: activity of L-dopa decarboxylase in discrete brain regions.
    Lloyd K; Hornykiewicz O
    Science; 1970 Dec; 170(3963):1212-3. PubMed ID: 5478194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histidine decarboxylase and DOPA decarboxylase in the rat stomach. Properties and cellular localization.
    Aures D; Håkanson R; Schauer A
    Eur J Pharmacol; 1968 Jun; 3(3):217-34. PubMed ID: 5673635
    [No Abstract]   [Full Text] [Related]  

  • 28. Liquid cation exchange--a basis for sensitive radiometric assays for aromatic amino acid decarboxylases.
    McCaman MW; McCaman RE; Lees GJ
    Anal Biochem; 1972 Jan; 45(1):242-52. PubMed ID: 4621556
    [No Abstract]   [Full Text] [Related]  

  • 29. Subunit structure of 3, 4-dihydroxyphenylalanine decarboxylase from pig kidney.
    Voltattorni CB; Minelli A; Cirotto C; Barra D; Turano C
    Arch Biochem Biophys; 1982 Aug; 217(1):58-64. PubMed ID: 7125679
    [No Abstract]   [Full Text] [Related]  

  • 30. CATECHOLAMINES, BIOSYNTHESIS AND INHIBITORS OF FORMATION.
    WEISS B; ROSSI GV
    Am J Pharm Sci Support Public Health; 1963 Jun; 135():206-18. PubMed ID: 14046042
    [No Abstract]   [Full Text] [Related]  

  • 31. DOPA decarboxylase activity in a transplantable hamster melanoma.
    Håkanson R; Möller H; Stormby NG
    Experientia; 1965 May; 21(5):265-6. PubMed ID: 5841256
    [No Abstract]   [Full Text] [Related]  

  • 32. A rapid assay and partial purification of dopa decarboxylase.
    Laduron P; Belpaire F
    Anal Biochem; 1968 Nov; 26(2):210-8. PubMed ID: 5758041
    [No Abstract]   [Full Text] [Related]  

  • 33. Decline of histidine decarboxylase activity and histamine levels in rat stomach after reserpine.
    Isaac L; Cho AK; Beaven MA
    Biochem Pharmacol; 1971 Jul; 20(7):1453-61. PubMed ID: 5163084
    [No Abstract]   [Full Text] [Related]  

  • 34. Automated radiometric assays of enzymatic and nonenzymatic oxidation of DOPA in vitro.
    Tran N
    J Lab Clin Med; 1974 Aug; 84(2):287-91. PubMed ID: 4843233
    [No Abstract]   [Full Text] [Related]  

  • 35. Histidine decarboxylase and DOPA decarboxylase in the stomach of the developing rat.
    Aures D; Håkanson R
    Experientia; 1968 Jul; 24(7):666-7. PubMed ID: 5705217
    [No Abstract]   [Full Text] [Related]  

  • 36. On the use of ethanol as a scavenger in storing labelled dopa and 5-hydroxytryptamine in aqueous solutions.
    Waldeck B
    J Pharm Pharmacol; 1973 Jun; 25(6):502-3. PubMed ID: 4146596
    [No Abstract]   [Full Text] [Related]  

  • 37. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
    Gattringer B; Steinhäusl H
    Wien Med Wochenschr; 1972 Jun; 122(25):369-71. PubMed ID: 4558132
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G; Pletscher A
    J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
    [No Abstract]   [Full Text] [Related]  

  • 39. Decarboxylation of DL-2,4-dihydroxyphenylalanine (2,4-DOPA) to 2,4-dihydroxyphenylethylamine in mouse striatal slices.
    Orosz D; Cohen G
    Eur J Pharmacol; 1987 Apr; 136(3):441-4. PubMed ID: 3111867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in tyrosine hydroxylase and dopa decarboxylase induced by pharmacological agents.
    Dairman W; Christenson JG; Udenfriend S
    Pharmacol Rev; 1972 Jun; 24(2):269-89. PubMed ID: 4404613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.